GlassScriptPhysician profile
Joel D Duff
NPI 1386038651
$3,239.05
in general payments reported to CMS, 2019-2025
28 companies · $436 in 2025
The $436 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $385 · 2021: $824 · 2022: $621 · 2023: $284 · 2024: $480 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,121 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $78.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,121.44 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $78.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $744.60 | 2020-2025 | Lithovue, Axonics |
| Dendreon Pharmaceuticals LLC | $353.97 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $284.79 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $256.37 | 2023-2025 | Gemtesa |
| Astellas Pharma US INC | $173.32 | 2021-2025 | Xtandi |
| Cook Medical LLC | $150.58 | 2021-2024 | Cook |
| Janssen Biotech, INC. | $133.55 | 2021 | |
| Myriad Genetic Laboratories, INC. | $129.10 | 2022-2024 | Prolaris |
| Allergan, INC. | $114.59 | 2019-2021 | |
| Tolmar, INC. | $113.44 | 2023-2024 | |
| Procept Biorobotics Corporation | $101.76 | 2024-2025 | Aquabeam System |
| Abbvie INC. | $99.02 | 2020-2023 | Lupron Depot |
| Tolmar Pharmaceuticals, INC. | $79.78 | 2021-2022 | |
| Urogen Pharma, INC. | $68.51 | 2022-2025 | |
| Coloplast Corp | $60.56 | 2020-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $50.65 | 2021-2022 | |
| Olympus America INC. | $48.93 | 2024-2025 | Itind System |
| Ferring Pharmaceuticals INC. | $39.28 | 2025 | Adstiladrin |
| Karl Storz Endoscopy-America | $36.31 | 2021 | |
| Calyxo, INC. | $32.50 | 2025 | Cvac Aspiration System |
| Progenics Pharmaceuticals, INC. | $31.21 | 2022 | |
| Acerus Pharmaceuticals Corporation | $29.25 | 2021 | |
| Amgen INC. | $26.60 | 2021 | |
| Accord Healthcare, INC. | $18.96 | 2023 | |
| Hollister Incorporated | $17.35 | 2022 | |
| Axonics, INC. | $17.07 | 2023 | Bulkamid |
| Teleflex LLC | $14.91 | 2024 | Urolift |
| Pfizer INC. | $12.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Duff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.